Ampersand Capital Partners has completed an investment in AnaBios Corp., according to a news release.
AnaBios, based in San Diego, is preclinical contract research organization. Founded in 2009, the company’s research focuses primarily on areas including cardiac disease and safety, pain, polycystic kidney disease and neurodegeneration.
Ampersand, based in Wellesley, Mass., is